A citation-based method for searching scientific literature

Alena Grebe, Florian Hoss, Eicke Latz. Circ Res 2018
Times Cited: 266







List of co-cited articles
838 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
43

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
35

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
819
16

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
Geena Paramel Varghese, Lasse Folkersen, Rona J Strawbridge, Bente Halvorsen, Arne Yndestad, Trine Ranheim, Kirsten Krohg-Sørensen, Mona Skjelland, Terje Espevik, Pål Aukrust,[...]. J Am Heart Assoc 2016
139
16

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation.
Nathan Kelley, Devon Jeltema, Yanhui Duan, Yuan He. Int J Mol Sci 2019
639
14

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
Thomas van der Heijden, Eva Kritikou, Wouter Venema, Janine van Duijn, Peter J van Santbrink, Bram Slütter, Amanda C Foks, Ilze Bot, Johan Kuiper. Arterioscler Thromb Vasc Biol 2017
163
13

NLRP3 inflammasome: Its regulation and involvement in atherosclerosis.
Zahra Hoseini, Fatemeh Sepahvand, Bahman Rashidi, Amirhossein Sahebkar, Aria Masoudifar, Hamed Mirzaei. J Cell Physiol 2018
222
13

A role for mitochondria in NLRP3 inflammasome activation.
Rongbin Zhou, Amir S Yazdi, Philippe Menu, Jürg Tschopp. Nature 2011
13

The NLRP3 inflammasome: molecular activation and regulation to therapeutics.
Karen V Swanson, Meng Deng, Jenny P-Y Ting. Nat Rev Immunol 2019
12

Role of NLRP3 Inflammasomes in Atherosclerosis.
Tadayoshi Karasawa, Masafumi Takahashi. J Atheroscler Thromb 2017
125
12

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.
Jianjin Shi, Yue Zhao, Kun Wang, Xuyan Shi, Yue Wang, Huanwei Huang, Yinghua Zhuang, Tao Cai, Fengchao Wang, Feng Shao. Nature 2015
12

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Rebecca C Coll, Avril A B Robertson, Jae Jin Chae, Sarah C Higgins, Raúl Muñoz-Planillo, Marco C Inserra, Irina Vetter, Lara S Dungan, Brian G Monks, Andrea Stutz,[...]. Nat Med 2015
12

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.
Magnus Bäck, Arif Yurdagul, Ira Tabas, Katariina Öörni, Petri T Kovanen. Nat Rev Cardiol 2019
371
11

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.
Kristiina Rajamäki, Jani Lappalainen, Katariina Oörni, Elina Välimäki, Sampsa Matikainen, Petri T Kovanen, Kari K Eklund. PLoS One 2010
592
11

Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.
Hirokazu Kirii, Tamikazu Niwa, Yasuhiro Yamada, Hisayasu Wada, Kuniaki Saito, Yoichiro Iwakura, Masahide Asano, Hisataka Moriwaki, Mitsuru Seishima. Arterioscler Thromb Vasc Biol 2003
533
11

Inflammasomes: mechanism of assembly, regulation and signalling.
Petr Broz, Vishva M Dixit. Nat Rev Immunol 2016
11

Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis.
Xin Shi, Wen-Li Xie, Wei-Wei Kong, Dong Chen, Peng Qu. J Stroke Cerebrovasc Dis 2015
67
16

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
Michael A Gimbrone, Guillermo García-Cardeña. Circ Res 2016
11

K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo, Peter Kuffa, Giovanny Martínez-Colón, Brenna L Smith, Thekkelnaycke M Rajendiran, Gabriel Núñez. Immunity 2013
11

Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
468
10

NLRP3 inflammasome pathways in atherosclerosis.
Marta Baldrighi, Ziad Mallat, Xuan Li. Atherosclerosis 2017
110
10

Gout-associated uric acid crystals activate the NALP3 inflammasome.
Fabio Martinon, Virginie Pétrilli, Annick Mayor, Aubry Tardivel, Jürg Tschopp. Nature 2006
10


Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.
Yang Yang, Huanan Wang, Mohammed Kouadir, Houhui Song, Fushan Shi. Cell Death Dis 2019
430
10

Mechanism and Regulation of NLRP3 Inflammasome Activation.
Yuan He, Hideki Hara, Gabriel Núñez. Trends Biochem Sci 2016
10

Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.
Nobuhiko Kayagaki, Irma B Stowe, Bettina L Lee, Karen O'Rourke, Keith Anderson, Søren Warming, Trinna Cuellar, Benjamin Haley, Merone Roose-Girma, Qui T Phung,[...]. Nature 2015
10

NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
Yuan He, Melody Y Zeng, Dahai Yang, Benny Motro, Gabriel Núñez. Nature 2016
510
10

Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
384
10

The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
Gerardus P J van Hout, Lena Bosch, Guilielmus H J M Ellenbroek, Judith J de Haan, Wouter W van Solinge, Matthew A Cooper, Fatih Arslan, Saskia C A de Jager, Avril A B Robertson, Gerard Pasterkamp,[...]. Eur Heart J 2017
188
9

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
526
9

Macrophages in atherosclerosis: a dynamic balance.
Kathryn J Moore, Frederick J Sheedy, Edward A Fisher. Nat Rev Immunol 2013
9

Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Renqing Wang, Yiqin Wang, Nana Mu, Xiaoying Lou, Weixuan Li, Yanming Chen, Dong Fan, Hongmei Tan. Lab Invest 2017
72
11

The NLRP3 inflammasome in acute myocardial infarction.
Stefano Toldo, Antonio Abbate. Nat Rev Cardiol 2018
250
8


CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.
Frederick J Sheedy, Alena Grebe, Katey J Rayner, Parisa Kalantari, Bhama Ramkhelawon, Susan B Carpenter, Christine E Becker, Hasini N Ediriweera, Adam E Mullick, Douglas T Golenbock,[...]. Nat Immunol 2013
537
8

Targeting the NLRP3 inflammasome in inflammatory diseases.
Matthew S J Mangan, Edward J Olhava, William R Roush, H Martin Seidel, Gary D Glick, Eicke Latz. Nat Rev Drug Discov 2018
486
8

Thioredoxin-interacting protein links oxidative stress to inflammasome activation.
Rongbin Zhou, Aubry Tardivel, Bernard Thorens, Inpyo Choi, Jürg Tschopp. Nat Immunol 2010
8

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death.
Jianjin Shi, Wenqing Gao, Feng Shao. Trends Biochem Sci 2017
858
8

The inflammasomes.
Kate Schroder, Jurg Tschopp. Cell 2010
8


Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice.
Delphine Gomez, Richard A Baylis, Brittany G Durgin, Alexandra A C Newman, Gabriel F Alencar, Sidney Mahan, Cynthia St Hilaire, Werner Müller, Ari Waisman, Sheila E Francis,[...]. Nat Med 2018
115
7

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.
P Menu, M Pellegrin, J-F Aubert, K Bouzourene, A Tardivel, L Mazzolai, J Tschopp. Cell Death Dis 2011
165
7

Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility.
Han Xiao, Min Lu, Ting Yang Lin, Zhen Chen, Gang Chen, Wei-Chi Wang, Traci Marin, Tzu-Pin Shentu, Liang Wen, Brendan Gongol,[...]. Circulation 2013
170
7

Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.
Anette Christ, Patrick Günther, Mario A R Lauterbach, Peter Duewell, Debjani Biswas, Karin Pelka, Claus J Scholz, Marije Oosting, Kristian Haendler, Kevin Baßler,[...]. Cell 2018
412
7

C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
7

Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.
Kiichi Nakahira, Jeffrey Adam Haspel, Vijay A K Rathinam, Seon-Jin Lee, Tamas Dolinay, Hilaire C Lam, Joshua A Englert, Marlene Rabinovitch, Manuela Cernadas, Hong Pyo Kim,[...]. Nat Immunol 2011
7

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.
Hua Jiang, Hongbin He, Yun Chen, Wei Huang, Jinbo Cheng, Jin Ye, Aoli Wang, Jinhui Tao, Chao Wang, Qingsong Liu,[...]. J Exp Med 2017
265
7


Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
Fei Zheng, Shanshan Xing, Zushun Gong, Wei Mu, Qichong Xing. Mediators Inflamm 2014
90
7

VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis.
Yiyi Li, Xuan Niu, Haitao Xu, Qingwen Li, Lanxia Meng, Mingyang He, Jie Zhang, Zhentao Zhang, Zhaohui Zhang. Exp Cell Res 2020
30
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.